Zobrazeno 1 - 10
of 428
pro vyhledávání: '"F. Luderer"'
Autor:
Yuri A. Maricich, Edward V. Nunes, Aimee N. C. Campbell, Jeffrey D. Botbyl, Hilary F. Luderer
Publikováno v:
Substance abuse. 43(1)
Autor:
Benjamin Parcher, Dylan Mezzio, Hilary F. Luderer, Fulton Velez, Robert Gerwien, Daniel C. Malone
Publikováno v:
Postgraduate Medicine. 133:421-427
Background: The opioid epidemic continues to generate a significant mental and physical health burden on patients, and claims the life of almost 150 Americans daily. Making matters worse, an increase in relapses and/or opioid-related deaths has been
Autor:
Steven C. Rozycki, Xiaorui Xiong, Paul Walter, Jessica Wright, Hilary F. Luderer, Stephen Braun, Yuri A. Maricich, James Purvis
Publikováno v:
CNS Spectrums. 27:237-238
IntroductionThe opioid epidemic in the United States is getting worse: in 2020 opioid overdose deaths hit an all-time high of 92,183. This underscored the need for more effective and readily available treatments for patients with opioid use disorder
Autor:
Lee M. Ritterband, Frances P. Thorndike, Charles M. Morin, Robert Gerwien, Nicole M. Enman, Ray Xiong, Hilary F. Luderer, Samantha Edington, Stephen Braun, Yuri A. Maricich
Publikováno v:
Behaviour Research and Therapy. 153:104084
There have been many research trials of various digital therapeutics, but few real world evaluations of their efficacy. This type of data, however, can provide a more rounded understanding of their impact, utility, reach, and adoption. Findings prese
Autor:
Robert Gerwien, Hilary F. Luderer, Alice Kuo, Keely Boyer, Yuri A. Maricich, Karren Williams, Stephen Braun, Xiaorui Xiong, Fulton Velez, Bruce Imbert
Publikováno v:
Current medical research and opinion. 37(2)
To evaluate patient engagement and usage of a prescription digital therapeutic (PDT) and associated outcomes of opioid use and treatment retention in a large real-world dataset of patients with opioid use disorder (OUD) treated with buprenorphine med
Autor:
Warren K. Bickel, Jeffrey Botbyl, Yuri A. Maricich, Kirstin M. Gatchalian, Hilary F. Luderer, Lisa A. Marsch
Publikováno v:
Curr Med Res Opin
OBJECTIVES: To evaluate the safety and efficacy of a digital therapeutic in treatment-seeking individuals with opioid use disorder (OUD) in an analysis of randomized clinical trial (RCT) data (ClinicalTrials.gov identifier: NCT00929253). METHODS: Sec
Autor:
Edward V. Nunes, Yuri A. Maricich, Nicole M. Enman, Aimee N.C. Campbell, Robert Gerwien, Hilary F. Luderer, Xiaorui Xiong
Publikováno v:
Journal of substance abuse treatment. 132
Introduction Patient engagement may play a key role in the success or failure of treatments for substance use disorder (SUD). This exploratory analysis of data from a large, multisite effectiveness trial ( NCT01104805 ) sought to determine how patien
Autor:
Hilary F. Luderer, Suky Martinez, Aimee N.C. Campbell, Bruce Imbert, Robert Gerwien, Xiaorui Xiong, Yuri A. Maricich, Mark Deeg, Christina Brezing, Lisa M. Chiodo, Amanda Wilson
Publikováno v:
JMIR Research Protocols. 11:e32759
Background Prescription digital therapeutics are software-based disease treatments that are regulated by the US Food and Drug Administration; the reSET-O prescription digital therapeutic was authorized in 2018 and delivers behavioral treatment for in
Autor:
Garyfallia Papaioannou, Claudia Dall'Osso, Hilary F. Luderer, Marie B. Demay, Christine M. Miller, Amy J. Wagers, Lige Song, Hengguang Zhao, Rosalynn M. Nazarian
Publikováno v:
Endocrinology. 157(10)
Ligand-dependent actions of the vitamin D receptor (VDR) play a pleiotropic role in the regulation of innate and adaptive immunity. The liganded VDR is required for recruitment of macrophages during the inflammatory phase of cutaneous wound healing.
Publikováno v:
Journal of Biological Chemistry. 286:18444-18451
Ligand-independent actions of the vitamin D receptor (VDR) are required for normal post-morphogenic hair cycles; however, the molecular mechanisms by which the VDR exerts these actions are not clear. Previous studies demonstrated impaired regulation